ロード中...
CD81 as target for B cell lymphomas
In this issue of JEM, Vences-Catalán et al. (https://doi.org/10.1084/jem.20190186) demonstrate that a particular anti-CD81 antibody shows promising features as a novel immunotherapeutic tool to treat B cell lymphomas. Surprisingly, although CD81 is widely expressed, only minor side effects on other...
保存先:
| 出版年: | J Exp Med |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Rockefeller University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6605746/ https://ncbi.nlm.nih.gov/pubmed/31171705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20190733 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|